CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.

RCMI Coordinating Center (RCMI CC)

CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication.

Singh UP, Venkataraman C, Singh R, Lillard JW. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets. 2007 Jun; 7(2):111-23.

View in: PubMed

subject areas

Animals
Colitis
Disease Models, Animal
Humans
Inflammatory Bowel Diseases
Ligands
Receptors, Chemokine
Receptors, CXCR3

authors with profiles

James Lillard
Rajesh Singh

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support